GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14272
Submission : 1999-06-15
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37885
Submission : 2022-12-20
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27522
Submission : 2013-09-09
Status : Inactive
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7507
Submission : 1988-06-02
Status : Inactive
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37885
Submission : 2022-12-20
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14272
Submission : 1999-06-15
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7507
Submission : 1988-06-02
Status : Inactive
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27522
Submission : 2013-09-09
Status : Inactive
Type : IV
FINISHED DOSAGE FORMULATIONS
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 211796
Country : US
Patented : No
Drug : CYCLOBENZAPRINE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 206703
Country : US
Patented : No
Drug : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 214476
Country : US
Patented : No
DEXMETHYLPHENIDATE HYDROCHLORIDE
Drug : DEXMETHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 79108
Country : US
Patented : No
DEXMETHYLPHENIDATE HYDROCHLORIDE
Drug : DEXMETHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 203614
Country : US
Patented : No
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 91695
Country : US
Patented : No
Drug : DIETHYLPROPION HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 91680
Country : US
Patented : No
DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Drug : DELSTRIGO
Dosage Form : TABLET; ORAL
Application Number : 210807
Country : US
Patented : Yes
HYPROMELLOSE ACETATE SUCCINATE
Route : ORAL
CAS : 71138971
UNII : NA
Potency Amount : 44.6
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
HYPROMELLOSE ACETATE SUCCINATE
Route : ORAL
CAS : 71138971
UNII : NA
Potency Amount : 66.78
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
HYPROMELLOSE ACETATE SUCCINATE
Route : ORAL
CAS : 71138971
UNII : NA
Potency Amount : 24.29
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
HYPROMELLOSE ACETATE SUCCINATE
Route : ORAL
CAS : 71138971
UNII : NA
Potency Amount : 560
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
HYPROMELLOSE ACETATE SUCCINATE
Route : ORAL
CAS : 71138971
UNII : NA
Potency Amount : 50.4
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
HYPROMELLOSE ACETATE SUCCINATE
Route : ORAL
CAS : 71138971
UNII : NA
Potency Amount : 325
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
HYPROMELLOSE ACETATE SUCCINATE
Route : ORAL
CAS : 71138971
UNII : NA
Potency Amount : 0
Potency Unit : NA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
Reply
18 Apr 2020
LOOKING FOR A SUPPLIER?